Comparison of neoadjuvant and adjuvant chemotherapy for upper tract urothelial carcinoma in real-world practice: a multicenter retrospective studyKazuhiro Takahashi, Takahiro Kimura, Minoru Nakazono et al.|Japanese Journal of Clinical Oncology|2023Cited by 13
En Bloc Resection Versus Conventional TURBT for T1HG Bladder Cancer: A Propensity Score-Matched AnalysisTakafumi Yanagisawa, Takahiro Kimura, Akihiro Matsukawa et al.|Annals of Surgical Oncology|2023Cited by 13
Real-world outcomes of adjuvant immunotherapy candidates with upper tract urothelial carcinoma: results of a multicenter cohort studyHirokazu Kagawa, Fumihiko Urabe, Yuria Kiuchi et al.|International Journal of Clinical Oncology|2023Cited by 10
Prognostic significance of subclassifying pathological <scp>T3</scp> upper tract urothelial carcinoma: Results from a multicenter cohort studyYushi Suhara, Fumihiko Urabe, Kentaro Yoshihara et al.|International Journal of Urology|2023Cited by 8
Effect of a variant histology on the oncological outcomes of Japanese patients with upper tract urothelial carcinomas after radical nephroureterectomy: a multicenter retrospective studyTakahiro Kimura, Naoki Uchida, Fumihiko Urabe et al.|Translational Andrology and Urology|2024Cited by 5